Detection of the COWP-associated target
Amplification meeting the study’s operational Ct criterion (Ct < 40) was observed in three of the 12 fecal samples (25%). The positive samples originated from two Holstein calves aged 7 and 10 days and one Barbarine sheep aged 10 days, with Ct values of 33.85, 35.81 and 38.80, respectively (Table 1). All three positive samples came from animals with recorded diarrhea. The four samples obtained from sheep without reported clinical signs were negative. These findings describe the amplification results observed in the sampled animals and do not establish a causal relationship between the detected target and diarrhea. Moreover, amplification with the COWP-targeting assay does not independently confirm the identity of the detected organism at the species level. The diversity of
Cryptosporidium species and genotypes reported in humans and animals reinforces the importance of appropriate molecular confirmation when species-level identification is intended (
Fayer, 2004;
Ryan et al., 2014). Previous studies have investigated
Cryptosporidium in young ruminants using different diagnostic and molecular approaches, including molecular characterization in goat kids
(Dixit et al., 2018) and buffalo calves
(Swain et al., 2018). More recently,
Mishra et al., (2025) documented
Cryptosporidium infection in goats, further illustrating the continued veterinary relevance of this parasite. However, differences in host species, sample sizes, sampling strategies and diagnostic methods preclude direct comparison of these findings with the amplification proportions observed in the present exploratory sample set.
Within the six calf samples, two showed amplification (33.3%). Within the six sheep samples, one showed amplification (16.7%). These proportions describe only the animals included in this small sample set. They should not be interpreted as estimates of infection prevalence in the wider cattle or sheep populations in Tunisia.
The observed Ct values were relatively high, particularly for sample 9. A Ct value reflects the point at which fluorescence crosses the defined threshold under a particular assay setup; it should not be interpreted directly as a measure of parasite burden without an appropriate calibration and validation framework. The results are therefore reported as observed amplification values rather than as quantitative estimates of parasite load. The positive control showed amplification, whereas the no-template control (NTC) showed no amplification.
Internal process control results
The internal process control (IPC) yielded Ct values ranging from 17.3 to 20.7 across the extracts. Detection of the IPC indicates that the control target could be amplified in the tested reactions. These results provide useful information when considering possible amplification inhibition.
However, the IPC results do not, by themselves, establish the extraction efficiency for
Cryptosporidium oocysts or demonstrate the recovery of parasite DNA from feces. Such conclusions would require a suitable extraction control design and a documented recovery assessment. The separate reference-control recovery estimates obtained from NanoDrop measurements are not interpreted as direct measurements of IPC recovery.
Interpretation of the exploratory concentration series
The available concentration series showed recorded Ct values across several DNA concentrations, as reported in Table 2. The lowest concentration tested, 0.002 ng/µL, was recorded as not detected (ND), whereas amplification was observed at concentrations of 0.004 ng/µL and above. These findings describe the amplification pattern under the conditions tested but do not establish a formal analytical limit of detection. Such a limit requires a defined validation procedure, sufficient replicate testing at relevant low concentrations and documented detection criteria. Similarly, amplification efficiency, linearity, slope and coefficient of determination cannot be reliably established without the underlying calibration data and appropriate statistical analysis. Accordingly, the concentration-series results are interpreted descriptively and are not used to claim a validated analytical limit of detection or complete analytical performance.
Assay specificity and species-level interpretation
The assay targeted the COWP gene and included a positive control containing
C. parvum DNA. However, the use of this target and positive control does not establish species-specific detection of
C. parvum. The primer/probe set used in this study was not experimentally assessed against other
Cryptosporidium species or relevant non-target organisms. Furthermore, no independent molecular confirmation, sequencing, or parallel assay targeting a second locus was available for the three positive fecal samples. Accordingly, the results are interpreted as amplification of the COWP-associated target and cannot be considered definitive species-level identification or used to distinguish
C. parvum from other
Cryptosporidium species.
Future investigations should include an independent molecular target, such as a suitably validated 18S rRNA assay and/or sequencing of the relevant amplicon, where appropriate. The specificity of the assay should also be assessed against relevant non-target organisms. The 18S rRNA gene is widely used in
Cryptosporidium molecular studies because it contains conserved and variable regions that can support detection and taxonomic characterization. However, its suitability for species discrimination depends on the selected region, primer design and analytical approach. Therefore, an 18S rRNA assay would provide an independent line of evidence but would not automatically guarantee species-level identification.
Methodological considerations and study limitations
The modified CTAB extraction procedure was used to obtain DNA from fecal material, with liquid-nitrogen pretreatment and an internal process control (IPC) added before DNA extraction. Although CTAB-based extraction methods have been widely used for nucleic-acid isolation, the resistance of
Cryptosporidium oocysts to disruption makes it important to assess extraction performance specifically for this organism. The present data do not establish that the extraction procedure achieves a particular level of oocyst disruption or parasite-DNA recovery. The recovery of amplifiable DNA from fecal samples can be affected by the efficiency of oocyst disruption, the quality of the extracted nucleic acids and the presence of substances that inhibit PCR. These factors should therefore be considered when evaluating molecular detection workflows for
Cryptosporidium (Jiang et al., 2005; Aboelsoued and Abdel, 2022).
The study has several limitations. First, the sample set comprised only 12 animals, which restricts the generalizability of the observed proportions. Second, the positive results were not independently confirmed using a second molecular target or sequencing. Third, the available concentration-series records do not provide a sufficient basis for reporting a complete set of analytical validation parameters. Finally, the sample set included animals with diarrhea and four sheep without reported clinical signs and the study was not designed to assess causal relationships between the detected target and clinical disease.
Despite these limitations, the investigation documents the application of a COWP-targeting TaqMan real-time PCR workflow to fecal samples from young cattle and sheep in Tunisia. The findings provide preliminary observations that may inform the design of a larger and more comprehensive evaluation.